BRIGHTEDGE FUND
BrightEdge is the American Cancer Society’s donor-funded, philanthropic impact fund. The fund is led by a board comprised of the Society’s leaders and a management team with expertise in investment and venture capital. BrightEdge operates under a charitable fund model that invests in for-profit companies developing novel cancer-focused therapies and technologies. The fund relies on the expertise of the Society’s medical and science professionals to evaluate the mission value of its investments. The fund’s goal is to accelerate delivery of promising cancer-related solutions through capital investment, market awareness and a shared commitment to eradicate cancer.
BRIGHTEDGE FUND
Industry:
Finance Financial Services Venture Capital
Founded:
2018-01-01
Status:
Active
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SSL By Default LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager Apache Euro Amazon Organization Schema
Similar Organizations
The BFM Fund
The BFM Fund aims to provide a direct funding path for black founders.
GroundFloor
The GroundFloor impact accelerator fund at United Way of Metropolitan Dallas.
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2022-07-20 | Auron Therapeutics | BrightEdge Fund investment in Series A - Auron Therapeutics | 48 M USD |
| 2022-07-19 | Persephone Biosciences | BrightEdge Fund investment in Seed Round - Persephone Biosciences | 15 M USD |
| 2022-01-26 | CellCentric | BrightEdge Fund investment in Venture Round - CellCentric | N/A |
| 2021-12-07 | Freenome | BrightEdge Fund investment in Series D - Freenome | 300 M USD |
| 2021-11-17 | Alpheus Medical | BrightEdge Fund investment in Series A - Alpheus Medical | 16 M USD |
| 2021-09-29 | TailorMed | BrightEdge Fund investment in Venture Round - TailorMed | 5 M USD |
| 2021-08-18 | Immunitas Therapeutics | BrightEdge Fund investment in Series B - Immunitas Therapeutics | 58 M USD |
| 2021-05-18 | Interius BioTherapeutics | BrightEdge Fund investment in Series A - Interius BioTherapeutics | 76 M USD |
| 2021-01-28 | Auron Therapeutics | BrightEdge Fund investment in Seed Round - Auron Therapeutics | 12.75 M USD |
| 2020-08-26 | Freenome | BrightEdge Fund investment in Series C - Freenome | 270 M USD |
More informations about "BrightEdge Fund"
BrightEdge | Cancer Social Impact Investing | Cancer Impact Fund
BrightEdge is the Philanthropic Impact Fund of the American Cancer Society aimed at investing in companies that accelerate the ACS mission to fight cancer. ... BrightEdge propels …See details»
About - acsbrightedge.org
BrightEdge is the innovation, impact investment and venture capital arm of the American Cancer Society. BrightEdge propels groundbreaking patient-centric solutions by accelerating ACS’s …See details»
BrightEdge Fund - Crunchbase Investor Profile & Investments
BrightEdge is the American Cancer Society’s donor-funded, philanthropic impact fund. The fund is led by a board comprised of the Society’s leaders and a management team with expertise in …See details»
American Cancer Society BrightEdge Fund 2021
Nonhealthcare cancer-fighting organization, ACS is working in more than 5,000 communities across the nation to improve the lives of cancer patients and their families. To accelerate our …See details»
Amplifying Innovation Driving Impact - American Cancer Society
BrightEdge, ACS is doubling down on our investment . in science to accelerate our mission to improve lives. BrightEdge strategically invests in start-up companies developing cancer …See details»
American Cancer Society BrightEdge Annual Report Reveals …
BOSTON, Oct. 28, 2024 – BrightEdge LLC, the American Cancer Society’s (ACS) venture capital and impact investment arm, has published its most recent annual report highlighting progress …See details»
THE FIGHT AGAINST CANCER - American Cancer Society
BrightEdge, LLC is the American Cancer Society’s innovation and impact investing arm. To learn more about BrightEdge and read the 2022 Annual Report, visit acsbrightedge.org. ACS Impact …See details»
Press Releases - American Cancer Society MediaRoom
Aug 16, 2023 BrightEdge was created by ACS in 2019 to build a sustainable stream of alternative income for the nation’s leading cancer-fighting organization while catalyzing market …See details»
American Cancer Society BrightEdge Annual Report Reveals …
Oct 28, 2024 ACS Impact Venture Fund (AIVF)'s active portfolio of 16 companies is transforming the fight against cancer through impact investing. BOSTON, Oct. 28, 2024 /PRNewswire/ -- …See details»
BrightEdge - American Cancer Society - LinkedIn
BrightEdge is the innovation, impact investment and venture capital arm of the American Cancer Society. Today, our donor-funded ACS Impact Venture Fund (AIVF) invests in for-profit, early-stage ...See details»
ACS BrightEdge Poised to Help Improve 1.5 Million Lives By …
Aug 16, 2023 BrightEdge was created by ACS in 2019 to build a sustainable stream of alternative income for the nation's leading cancer-fighting organization while catalyzing market …See details»
American Cancer Society's Impact Investment Fund Secures First …
Nov 16, 2021 Membership in the American Cancer Society BrightEdge Founder's Circle requires a minimum $500,000 commitment over four years. BrightEdge has set a fundraising and …See details»
American Cancer Society BrightEdge Annual Report Reveals …
ACS Impact Venture Fund (AIVF)’s active portfolio of 16 companies is ... BrightEdge’s annual report reflects the fund’s commitment to addressing the unequal impacts of ... The American …See details»
American Cancer Society’s Impact Venture Capital Arm Secures $1 …
BrightEdge oversees a fund with a net asset value of $77 million, which includes recent donations and an additional $40 million investment from the American Cancer Society. The fund invests …See details»
BrightEdge Fund - Investments, Portfolio & Company Exits
Oct 31, 2020 BrightEdge Fund 's most notable exits include Tmunity Therapeutics, Modifi Bio, and Castle Biosciences. Which industries has this organization had the most exits in? Show . …See details»
American Cancer Society BrightEdge Overview - YouTube
This video features Alice Pomponio, managing director of BrightEdge, the American Cancer Society's donor-funded, philanthropic impact investment fund, along ...See details»
BrightEdge Fund: Performance - PitchBook
BrightEdge Fund is a venture capital fund managed by BrightEdge. The fund is based in Kennesaw, Georgia, and invests in the United States, Canada, Europe, and Asia. The fund …See details»
Press Releases - pressroom.cancer.org
Jul 6, 2022 BrightEdge oversees a fund with a net asset value of $77 million, which includes recent donations and an additional $40 million investment from the American Cancer Society. …See details»
ACS BrightEdge Poised to Help Improve 1.5 Million Lives By …
ACS Impact Venture Fund (AIVF). These companies have collectively raised more than $3.1B for their cancer-fighting innovations. In its annual report, BrightEdge also announced $9.7M in …See details»